Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive approach. Supporters often stress the potential for significant therapeutic outcomes, particularly in conditions where conventional therapies have proven inadequate. However, crucially important to assess the significant financial expenditure associated with CPI s